Genome editing technology refers to the ability of human to "edit" the target gene, such as the deletion and addition of specific DNA fragments.
Market Analysis and Insights: Global Genome Editing/Genome Engineering Market
The global Genome Editing/Genome Engineering market size is projected to reach US$ 6739.8 million by 2028, from US$ 3513 million in 2021, at a CAGR of 9.3% during 2022-2028.
The CRISPR segment is estimated to grow at the highest CAGR during the forecast period.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Genome Editing/Genome Engineering market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Genome Editing/Genome Engineering market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Genome Editing/Genome Engineering market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Genome Editing/Genome Engineering market.
Global Genome Editing/Genome Engineering Scope and Market Size
Genome Editing/Genome Engineering market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Genome Editing/Genome Engineering market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Segment by Application
- Cell Line Engineering
- Animal Genetic Engineering
- Plant Genetic Engineering
By Company
- Thermo Fisher Scientific
- Merck
- Horizon Discovery
- Genscript
- Sangamo Biosciences
- Integrated Dna Technologies
- Lonza
- New England Biolabs
- Origene Technologies
- Transposagen Biopharmaceuticals
- Editas Medicine
- Crispr Therapeutics
By Region
- North America
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
TABLE OF CONTENTS
1 Report Business Overview
- 1.1 Study Scope
- 1.2 Market Analysis by Type
- 1.2.1 Global Genome Editing/Genome Engineering Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
- 1.2.2 CRISPR
- 1.2.3 TALEN
- 1.2.4 ZFN
- 1.3 Market by Application
- 1.3.1 Global Genome Editing/Genome Engineering Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
- 1.3.2 Cell Line Engineering
- 1.3.3 Animal Genetic Engineering
- 1.3.4 Plant Genetic Engineering
- 1.4 Study Objectives
- 1.5 Years Considered
2 Global Growth Trends
- 2.1 Global Genome Editing/Genome Engineering Market Perspective (2017-2028)
- 2.2 Genome Editing/Genome Engineering Growth Trends by Region
- 2.2.1 Genome Editing/Genome Engineering Market Size by Region: 2017 VS 2021 VS 2028
- 2.2.2 Genome Editing/Genome Engineering Historic Market Size by Region (2017-2022)
- 2.2.3 Genome Editing/Genome Engineering Forecasted Market Size by Region (2023-2028)
- 2.3 Genome Editing/Genome Engineering Market Dynamics
- 2.3.1 Genome Editing/Genome Engineering Industry Trends
- 2.3.2 Genome Editing/Genome Engineering Market Drivers
- 2.3.3 Genome Editing/Genome Engineering Market Challenges
- 2.3.4 Genome Editing/Genome Engineering Market Restraints
3 Competition Landscape by Key Players
- 3.1 Global Top Genome Editing/Genome Engineering Players by Revenue
- 3.1.1 Global Top Genome Editing/Genome Engineering Players by Revenue (2017-2022)
- 3.1.2 Global Genome Editing/Genome Engineering Revenue Market Share by Players (2017-2022)
- 3.2 Global Genome Editing/Genome Engineering Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.3 Players Covered: Ranking by Genome Editing/Genome Engineering Revenue
- 3.4 Global Genome Editing/Genome Engineering Market Concentration Ratio
- 3.4.1 Global Genome Editing/Genome Engineering Market Concentration Ratio (CR5 and HHI)
- 3.4.2 Global Top 10 and Top 5 Companies by Genome Editing/Genome Engineering Revenue in 2021
- 3.5 Genome Editing/Genome Engineering Key Players Head office and Area Served
- 3.6 Key Players Genome Editing/Genome Engineering Product Solution and Service
- 3.7 Date of Enter into Genome Editing/Genome Engineering Market
- 3.8 Mergers & Acquisitions, Expansion Plans
4 Genome Editing/Genome Engineering Breakdown Data by Type
- 4.1 Global Genome Editing/Genome Engineering Historic Market Size by Type (2017-2022)
- 4.2 Global Genome Editing/Genome Engineering Forecasted Market Size by Type (2023-2028)
5 Genome Editing/Genome Engineering Breakdown Data by Application
- 5.1 Global Genome Editing/Genome Engineering Historic Market Size by Application (2017-2022)
- 5.2 Global Genome Editing/Genome Engineering Forecasted Market Size by Application (2023-2028)
6 North America
- 6.1 North America Genome Editing/Genome Engineering Market Size (2017-2028)
- 6.2 North America Genome Editing/Genome Engineering Market Size by Type
- 6.2.1 North America Genome Editing/Genome Engineering Market Size by Type (2017-2022)
- 6.2.2 North America Genome Editing/Genome Engineering Market Size by Type (2023-2028)
- 6.2.3 North America Genome Editing/Genome Engineering Market Share by Type (2017-2028)
- 6.3 North America Genome Editing/Genome Engineering Market Size by Application
- 6.3.1 North America Genome Editing/Genome Engineering Market Size by Application (2017-2022)
- 6.3.2 North America Genome Editing/Genome Engineering Market Size by Application (2023-2028)
- 6.3.3 North America Genome Editing/Genome Engineering Market Share by Application (2017-2028)
- 6.4 North America Genome Editing/Genome Engineering Market Size by Country
- 6.4.1 North America Genome Editing/Genome Engineering Market Size by Country (2017-2022)
- 6.4.2 North America Genome Editing/Genome Engineering Market Size by Country (2023-2028)
- 6.4.3 U.S.
- 6.4.4 Canada
7 Europe
- 7.1 Europe Genome Editing/Genome Engineering Market Size (2017-2028)
- 7.2 Europe Genome Editing/Genome Engineering Market Size by Type
- 7.2.1 Europe Genome Editing/Genome Engineering Market Size by Type (2017-2022)
- 7.2.2 Europe Genome Editing/Genome Engineering Market Size by Type (2023-2028)
- 7.2.3 Europe Genome Editing/Genome Engineering Market Share by Type (2017-2028)
- 7.3 Europe Genome Editing/Genome Engineering Market Size by Application
- 7.3.1 Europe Genome Editing/Genome Engineering Market Size by Application (2017-2022)
- 7.3.2 Europe Genome Editing/Genome Engineering Market Size by Application (2023-2028)
- 7.3.3 Europe Genome Editing/Genome Engineering Market Share by Application (2017-2028)
- 7.4 Europe Genome Editing/Genome Engineering Market Size by Country
- 7.4.1 Europe Genome Editing/Genome Engineering Market Size by Country (2017-2022)
- 7.4.2 Europe Genome Editing/Genome Engineering Market Size by Country (2023-2028)
- 7.4.3 Germany
- 7.4.4 France
- 7.4.5 U.K.
- 7.4.6 Italy
- 7.4.7 Russia
- 7.4.8 Nordic Countries
8 Asia-Pacific
- 8.1 Asia-Pacific Genome Editing/Genome Engineering Market Size (2017-2028)
- 8.2 Asia-Pacific Genome Editing/Genome Engineering Market Size by Type
- 8.2.1 Asia-Pacific Genome Editing/Genome Engineering Market Size by Type (2017-2022)
- 8.2.2 Asia-Pacific Genome Editing/Genome Engineering Market Size by Type (2023-2028)
- 8.2.3 Asia-Pacific Genome Editing/Genome Engineering Market Share by Type (2017-2028)
- 8.3 Asia-Pacific Genome Editing/Genome Engineering Market Size by Application
- 8.3.1 Asia-Pacific Genome Editing/Genome Engineering Market Size by Application (2017-2022)
- 8.3.2 Asia-Pacific Genome Editing/Genome Engineering Market Size by Application (2023-2028)
- 8.3.3 Asia-Pacific Genome Editing/Genome Engineering Market Share by Application (2017-2028)
- 8.4 Asia-Pacific Genome Editing/Genome Engineering Market Size by Region
- 8.4.1 Asia-Pacific Genome Editing/Genome Engineering Market Size by Region (2017-2022)
- 8.4.2 Asia-Pacific Genome Editing/Genome Engineering Market Size by Region (2023-2028)
- 8.4.3 China
- 8.4.4 Japan
- 8.4.5 South Korea
- 8.4.6 Southeast Asia
- 8.4.7 India
- 8.4.8 Australia
9 Latin America
- 9.1 Latin America Genome Editing/Genome Engineering Market Size (2017-2028)
- 9.2 Latin America Genome Editing/Genome Engineering Market Size by Type
- 9.2.1 Latin America Genome Editing/Genome Engineering Market Size by Type (2017-2022)
- 9.2.2 Latin America Genome Editing/Genome Engineering Market Size by Type (2023-2028)
- 9.2.3 Latin America Genome Editing/Genome Engineering Market Share by Type (2017-2028)
- 9.3 Latin America Genome Editing/Genome Engineering Market Size by Application
- 9.3.1 Latin America Genome Editing/Genome Engineering Market Size by Application (2017-2022)
- 9.3.2 Latin America Genome Editing/Genome Engineering Market Size by Application (2023-2028)
- 9.3.3 Latin America Genome Editing/Genome Engineering Market Share by Application (2017-2028)
- 9.4 Latin America Genome Editing/Genome Engineering Market Size by Country
- 9.4.1 Latin America Genome Editing/Genome Engineering Market Size by Country (2017-2022)
- 9.4.2 Latin America Genome Editing/Genome Engineering Market Size by Country (2023-2028)
- 9.4.3 Mexico
- 9.4.4 Brazil
10 Middle East & Africa
- 10.1 Middle East & Africa Genome Editing/Genome Engineering Market Size (2017-2028)
- 10.2 Middle East & Africa Genome Editing/Genome Engineering Market Size by Type
- 10.2.1 Middle East & Africa Genome Editing/Genome Engineering Market Size by Type (2017-2022)
- 10.2.2 Middle East & Africa Genome Editing/Genome Engineering Market Size by Type (2023-2028)
- 10.2.3 Middle East & Africa Genome Editing/Genome Engineering Market Share by Type (2017-2028)
- 10.3 Middle East & Africa Genome Editing/Genome Engineering Market Size by Application
- 10.3.1 Middle East & Africa Genome Editing/Genome Engineering Market Size by Application (2017-2022)
- 10.3.2 Middle East & Africa Genome Editing/Genome Engineering Market Size by Application (2023-2028)
- 10.3.3 Middle East & Africa Genome Editing/Genome Engineering Market Share by Application (2017-2028)
- 10.4 Middle East & Africa Genome Editing/Genome Engineering Market Size by Country
- 10.4.1 Middle East & Africa Genome Editing/Genome Engineering Market Size by Country (2017-2022)
- 10.4.2 Middle East & Africa Genome Editing/Genome Engineering Market Size by Country (2023-2028)
- 10.4.3 Turkey
- 10.4.4 Saudi Arabia
- 10.4.5 UAE
11 Key Players Profiles
- 11.1 Thermo Fisher Scientific
- 11.1.1 Thermo Fisher Scientific Company Details
- 11.1.2 Thermo Fisher Scientific Business Overview
- 11.1.3 Thermo Fisher Scientific Genome Editing/Genome Engineering Introduction
- 11.1.4 Thermo Fisher Scientific Revenue in Genome Editing/Genome Engineering Business (2017-2022)
- 11.1.5 Thermo Fisher Scientific Recent Developments
- 11.2 Merck
- 11.2.1 Merck Company Details
- 11.2.2 Merck Business Overview
- 11.2.3 Merck Genome Editing/Genome Engineering Introduction
- 11.2.4 Merck Revenue in Genome Editing/Genome Engineering Business (2017-2022)
- 11.2.5 Merck Recent Developments
- 11.3 Horizon Discovery
- 11.3.1 Horizon Discovery Company Details
- 11.3.2 Horizon Discovery Business Overview
- 11.3.3 Horizon Discovery Genome Editing/Genome Engineering Introduction
- 11.3.4 Horizon Discovery Revenue in Genome Editing/Genome Engineering Business (2017-2022)
- 11.3.5 Horizon Discovery Recent Developments
- 11.4 Genscript
- 11.4.1 Genscript Company Details
- 11.4.2 Genscript Business Overview
- 11.4.3 Genscript Genome Editing/Genome Engineering Introduction
- 11.4.4 Genscript Revenue in Genome Editing/Genome Engineering Business (2017-2022)
- 11.4.5 Genscript Recent Developments
- 11.5 Sangamo Biosciences
- 11.5.1 Sangamo Biosciences Company Details
- 11.5.2 Sangamo Biosciences Business Overview
- 11.5.3 Sangamo Biosciences Genome Editing/Genome Engineering Introduction
- 11.5.4 Sangamo Biosciences Revenue in Genome Editing/Genome Engineering Business (2017-2022)
- 11.5.5 Sangamo Biosciences Recent Developments
- 11.6 Integrated Dna Technologies
- 11.6.1 Integrated Dna Technologies Company Details
- 11.6.2 Integrated Dna Technologies Business Overview
- 11.6.3 Integrated Dna Technologies Genome Editing/Genome Engineering Introduction
- 11.6.4 Integrated Dna Technologies Revenue in Genome Editing/Genome Engineering Business (2017-2022)
- 11.6.5 Integrated Dna Technologies Recent Developments
- 11.7 Lonza
- 11.7.1 Lonza Company Details
- 11.7.2 Lonza Business Overview
- 11.7.3 Lonza Genome Editing/Genome Engineering Introduction
- 11.7.4 Lonza Revenue in Genome Editing/Genome Engineering Business (2017-2022)
- 11.7.5 Lonza Recent Developments
- 11.8 New England Biolabs
- 11.8.1 New England Biolabs Company Details
- 11.8.2 New England Biolabs Business Overview
- 11.8.3 New England Biolabs Genome Editing/Genome Engineering Introduction
- 11.8.4 New England Biolabs Revenue in Genome Editing/Genome Engineering Business (2017-2022)
- 11.8.5 New England Biolabs Recent Developments
- 11.9 Origene Technologies
- 11.9.1 Origene Technologies Company Details
- 11.9.2 Origene Technologies Business Overview
- 11.9.3 Origene Technologies Genome Editing/Genome Engineering Introduction
- 11.9.4 Origene Technologies Revenue in Genome Editing/Genome Engineering Business (2017-2022)
- 11.9.5 Origene Technologies Recent Developments
- 11.10 Transposagen Biopharmaceuticals
- 11.10.1 Transposagen Biopharmaceuticals Company Details
- 11.10.2 Transposagen Biopharmaceuticals Business Overview
- 11.10.3 Transposagen Biopharmaceuticals Genome Editing/Genome Engineering Introduction
- 11.10.4 Transposagen Biopharmaceuticals Revenue in Genome Editing/Genome Engineering Business (2017-2022)
- 11.10.5 Transposagen Biopharmaceuticals Recent Developments
- 11.11 Editas Medicine
- 11.11.1 Editas Medicine Company Details
- 11.11.2 Editas Medicine Business Overview
- 11.11.3 Editas Medicine Genome Editing/Genome Engineering Introduction
- 11.11.4 Editas Medicine Revenue in Genome Editing/Genome Engineering Business (2017-2022)
- 11.11.5 Editas Medicine Recent Developments
- 11.12 Crispr Therapeutics
- 11.12.1 Crispr Therapeutics Company Details
- 11.12.2 Crispr Therapeutics Business Overview
- 11.12.3 Crispr Therapeutics Genome Editing/Genome Engineering Introduction
- 11.12.4 Crispr Therapeutics Revenue in Genome Editing/Genome Engineering Business (2017-2022)
- 11.12.5 Crispr Therapeutics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.2 Data Source
- 13.2 Author Details
- 13.3 Disclaimer